Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 12

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

Total article views   HTML views PDF downloads Totals
9,051 Dovepress* 7,829+ 1,611 9,440
PubMed Central* 1,222 176 1,398
Totals 9,051 1,787 10,838
*Since 17 April 2019

View citations on PubMed Central and Google Scholar